Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00414518 · ClinicalTrials.gov registry record · NA
Safety and Effectiveness of Short-Term Anti-HIV Drug Therapy for Recent HIV-1 Infection
A NA study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT00414518 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 16 participants.
The verdict
NCT00414518, a NA study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the safety and effectiveness of an anti-HIV drug regimen followed by treatment interruption in people recently infected with HIV. This study will also compare the effects of a treatment regimen including treatment interruption with a treatment plan based on clinical indicators.
Interventions
- DRUG Lopinavir/Ritonavir
- DRUG Tenofovir disoproxil fumarate/Emtricitabine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2007-01 |
| Est. Completion | 2010-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00414518
The ClinicalTrials.gov registry entry for NCT00414518 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Lopinavir/Ritonavir is the first listed.
NCT00414518 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00414518 about?
NCT00414518 is a clinical study titled "Safety and Effectiveness of Short-Term Anti-HIV Drug Therapy for Recent HIV-1 Infection". The purpose of this study is to determine the safety and effectiveness of an anti-HIV drug regimen followed by treatment interruption in people recently infected with HIV. This study will also compare the effects of a treatment regimen including treatment interruption with a treatment plan based on ...
What is the current status of trial NCT00414518?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2007-01. Estimated completion is 2010-02.
What interventions are being tested in trial NCT00414518?
The interventions under investigation include: Lopinavir/Ritonavir (DRUG), Tenofovir disoproxil fumarate/Emtricitabine (DRUG).
Who is sponsoring clinical trial NCT00414518?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.